首页> 外文期刊>Peptides: An International Journal >Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f 1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice.
【24h】

Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f 1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice.

机译:静脉注射核糖毒素的主要和隐秘肽表位,Asp f 1抑制小鼠中烟曲霉粗品抗原诱导的T细胞反应。

获取原文
获取原文并翻译 | 示例
       

摘要

Aspergillus fumigatus, a ubiquitous fungus, is implicated in the pathogenesis of a number of clinically different allergic diseases in man. Peptide-based immunotherapy may offer an alternative in patient care and management. The purpose of this study was to evaluate the role of T cell epitopes of A. fumigatus ribotoxin, Asp f 1 in inducing tolerance in mice exposed to A. fumigatus antigen. The epitope analysis in BALB/c mice using synthetic peptides of Asp f 1 demonstrated both cryptic and dominant epitopes detected from 42 through 54 and 155 through 167 aa, accordingly. Intravenous injection of these peptides markedly inhibited the response induced by the exposure to crude A. fumigatus extract in mice as evidenced by the in vitro interleukin-2 (IL-2) production and proliferation of T-lymphocytes. Cytokine transcription studies indicate that, when stimulated with the peptides in immunogenic conditions, the major peptide (aa 155-167) specific T cell clone produced only IFN-gamma, but not IL-4. The ability of both dominant and cryptic peptide epitopes of a single molecule to induce tolerance against the immune response to a multi-molecular allergen complex has significant implication for peptide-based immunotherapy.
机译:烟曲霉是一种普遍存在的真菌,​​与人类许多临床上不同的过敏性疾病的发病机理有关。基于肽的免疫疗法可能会为患者的护理和管理提供另一种选择。这项研究的目的是评估烟曲霉核糖毒素,Asp f 1的T细胞表位在暴露于烟曲霉抗原的小鼠中诱导耐受的作用。因此,在BALB / c小鼠中使用Asp f 1的合成肽进行的表位分析表明,从42位至54位和155位至167位氨基酸均检测到隐性和显性表位。这些肽的静脉注射显着抑制了小鼠暴露于烟曲霉粗提物所引起的应答,体外白介素2(IL-2)的产生和T淋巴细胞的增殖证明了这一点。细胞因子转录研究表明,在免疫原性条件下用该肽刺激时,主要的肽(aa 155-167)特异性T细胞克隆仅产生IFN-γ,而不产生IL-4。单个分子的显性和隐性肽表位诱导针对多分子过敏原复合物的免疫反应的耐受性的能力对基于肽的免疫疗法具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号